Surgical Power Tools Research Report 2024-2029: Rising Customization in Surgical Power Tools, Increasing Preference for Minimally Invasive and Robotic Surgeries, Rising Orthopedic Surgeries
September 11, 2024 06:00 ET
|
Research and Markets
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Surgical Power Tools Market - Global Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Surgical Power...
Stereotaxis Reports 2024 Second Quarter Financial Results
August 12, 2024 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
August 12, 2024 16:03 ET
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
Globus Medical Reports Second Quarter 2024 Results
August 06, 2024 16:15 ET
|
Globus Medical
AUDUBON, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30,...
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
July 22, 2024 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
July 17, 2024 08:30 ET
|
Globus Medical
AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food...